Recruiting Clinical Trials

Displaying 1 - 10 of 213 result(s)
Study Title Condition Phase Location
An Open-label, Adaptive Design Study in Patients With Amyotrophic Lateral Sclerosis (ALS) to Characterize Safety, Tolerability and Brain Microglia Response, as Measured by TSPO Binding, Following Multiple Doses of BLZ945 Using Positron Emission Tomog ... Amyotrophic Lateral Sclerosis Phase 2
  • Country: 
    United States
  • Country: 
    Finland
  • Country: 
    Sweden
A First-in-human, Open-label, Single Ascending Dose Study to Assess Safety and Tolerability of Intravitreal MHU650 in Patients With Macular Edema Macular Edema, Diabetic Macular Edema, Neovascular Age-related Macular Degeneration, Retinal Vein Occlusion Phase 1
  • Country: 
    United States
  • Country: 
    Puerto Rico
A Multi-center, Open-label Study to Determine the Dose and Safety of Oral Asciminib in Pediatric Patients With Philadelphia Chromosome Positive Chronic Myeloid Leukemia in Chronic Phase (Ph+ CML-CP), Previously Treated With One or More Tyrosine Kinas ... Myeloid Leukemia, Philadelphia Positive Phase 1, Phase 2
  • Country: 
    France
  • Country: 
    Hungary
A Double-blind, Placebo-controlled, Randomized Dose-ranging Trial to Investigate Efficacy and Safety of Intravenous MIJ821 Infusion in Addition to Comprehensive Standard of Care on the Rapid Reduction of Symptoms of Major Depressive Disorder in Subje ... Major Depressive Disorder With Suicidal Ideation With Intent Phase 2
  • Country: 
    United States
  • Country: 
    Malaysia
  • Country: 
    Poland
  • Country: 
A Phase III, Multi-center, Open-label, Randomized Study of Oral Asciminib Versus Investigator Selected TKI in Patients With Newly Diagnosed Philadelphia Chromosome Positive Chronic Myelogenous Leukemia in Chronic Phase Chronic Myeloid Leukemia (CML) Philadelphia Chromosome Positive Phase 3
  • Country: 
    Czech Republic
  • Country: 
    France
  • Country: 
    Hungary
  • Country: 
A Single-arm, Open-label, Phase II Study of Sabatolimab in Combination With Azacitidine and Venetoclax in Adult Participants With High or Very High Risk Myelodysplastic Syndromes (MDS) as Per IPSS-R Criteria Myelodysplastic Syndrome (MDS) Phase 2
  • Country: 
    Belgium
  • Country: 
    France
  • Country: 
    Germany
  • Country: 
Two Part (Double-blind Inclisiran Versus Placebo [Year 1] Followed by Open-label Inclisiran [Year 2]) Randomized Multicenter Study to Evaluate Safety, Tolerability, and Efficacy of Inclisiran in Adolescents (12 to Less Than 18 Years) With Heterozygou ... Familial Hypercholesterolemia - Heterozygous Phase 3
  • Country: 
    United States
  • Country: 
    Australia
  • Country: 
    Brazil
  • Country: 
A 12-week, Multicenter, Randomized, Double-blind, Parallel-arm, Placebo-controlled Study to Assess the Efficacy and Safety of CSJ117, When Added to Existing Asthma Therapy in Patients ≥ 18 Years of Age With Severe Uncontrolled Asthma. Asthma Phase 2
  • Country: 
    United States
  • Country: 
    Argentina
  • Country: 
    Belgium
  • Country: 
Open-Label Rater-Blind Randomized Multi-Center Parallel-Arm Active- Comparator Study to Assess the Efficacy and Tolerability of Ofatumumab 20mg SC Monthly vs. First Line DMT - Physician's Choice in the Treatment of Newly Diagnosed RMS Multiple Sclerosis Phase 3
  • Country: 
    France
  • Country: 
    Germany
  • Country: 
    Spain
A Phase IIIb Study of the Safety and Efficacy of Tisagenlecleucel Out of Specification for Commercial Release in Patients Who Are Consistent With the Label Indication B-cell Acute Lymphoblastic Leukemia, Diffuse Large B-cell Lymphoma Phase 3
  • Country: 
    Canada
  • Country: 
    Japan